PharmaLex Group, a global service provider for the pharma and biotech industries, has announced a merger with consulting company PharSolution.
PharSolution has experience across regulatory affairs, market access, medical writing, pharmacovigilance, GxP and strategic advice, as well as partnerships with institutions and health authorities in Portugal and at the European Medicines Agency and European Commission.
“The merger with PharmaLex provides our clients with broader reach across all our key value areas” said Alex Ramos, CEO, PharSolution. “With a long-term commitment to customer satisfaction, we look forward to the opportunity to help more lifescience companies in the pursuit of excellence and to being able to offer our customers access to more markets and a broader base of compliance experts.”
“We are delighted to welcome the PharSolution team to the PharmaLex Group, and at the prospect of further expanding our technology-enabled service solutions portfolio with the integration of PharSolution’s three technology platforms that further enhance our existing pharmacovigilance databases globally,” said PharmaLex CEO Dr Thomas Dobmeyer. “The merger furthermore enables us to deliver local affiliate support in Portugal for all our solutions across our service centers – regulatory, pharmacovigilance, risk management, quality and manufacturing, strategic advice and scientific affairs – as we continue to build on our global approach while providing local support.”
